Clinical trials: Intravenous Substance Abuse
Substance Abuse, Intravenous, Prevention and Control
Break the Cycle: Prevention for Reducing Initiation Into Injection Drug Use
Break the Cycle is a two-session, one-on-one, in-person intervention study designed to reduce the role persons who inject drugs (PWID) play initiating non-PWID into injection drug use.
- Trial name
- NCT03502525
- Testing
- Break the Cycle Intervention, Bacterial Infection Prevention
- Where
- 2 sites in United States, Estonia
- Volunteers
- 402 people
- Sponsor
- New York University
Hepatitis C, Substance Use Disorders
Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care
hepatitis C virus (HCV) has traditionally been treated in subspecialty health centers given the complexity of older pegylated interferon containing regimens, formerly the standard of care.
- Conditions
- Hepatitis C, Substance Use Disorders, Substance Abuse, Intravenous
- Trial name
- NCT03093415
- Testing
- elbasvir-grazoprevir (50 mg/100 mg)
- Where
- 2 sites in United States
- Volunteers
- 100 people
- Sponsor
- Oregon Health and Science University
Medication Adherence, Substance Abuse, Intravenous
A Randomized Trial of Vaccine Adherence in Young Injection Drug Users
The purpose of this study is to compare the effects of (a) immunization setting and (b) outreach worker support on young injection drug users' (IDU) adherence to a multiple dose immunization schedule with a combined hepatitis A…
- Conditions
- Medication Adherence, Substance Abuse, Intravenous, Risk Behavior, Hepatitis A
- Trial name
- UFO VAX (NCT00244374)
- Testing
- Hepatitis A & B vaccine, Outreach, AIC
- Where
- United States
- Volunteers
- 546 people
- Sponsor
- University of California, San Francisco
Drug Abuse, Intravenous, Internet
Telemedicine and Social Media for People Who Inject Drugs (PWID) in Greece
The current study seeks to address questions regarding internet and social media usage as well as telemedicine concept and knowledge, by conducting targeted focus group discussions (FGDs) and administering cross-sectional…
- Conditions
- Drug Abuse, Intravenous, Internet, Social Media, Telemedicine
- Trial name
- NCT05794984
- Testing
- Focus group discussions and survey questionnaire
- Where
- Greece
- Volunteers
- 219 people
- Sponsor
- State University of New York at Buffalo
Drug Abuse, Intravenous
Case Management in HCV Infected PWID
To study the impact of case management on the outcome of the care of chronic hepatitis C in people who inject drugs (PWID). By creating the function of case manager, the investigators will target all the barriers to care of the…
- Trial name
- CM-HCV (NCT03106194)
- Testing
- case management
- Where
- Belgium
- Volunteers
- 441 people
- Sponsor
- Hasselt University
Nicotine Dependence, Drug Abuse
Effects of Nicotine on Brain Activity as Measured by fMRI
Background: Nicotine addiction is common among people who smoke tobacco, and the addictive properties of nicotine make smoking cessation difficult even for people who want to quit.
- Trial name
- NCT01037153
- Where
- United States
- Volunteers
- 128 people, healthy volunteers welcome
- Sponsor
- National Institute on Drug Abuse (NIDA)
Cocaine-Related Disorders
IV Cocaine Abuse: A Laboratory Model - 3
The purpose of this study is to evaluate the effects of buprenorpine on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.
- Trial name
- NCT00000214
- Testing
- Buprenorphine
- Where
- United States
- Sponsor
- New York State Psychiatric Institute
Gram-Positive Bacterial Infections, Gram-Positive Bacteraemia
Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition
The Investigators aim to study the outcomes of serious infections due to vancomycin susceptible infections in gram-positive organisms susceptible to vancomycin in people who use drugs (PWUD).
- Conditions
- Gram-Positive Bacterial Infections, Gram-Positive Bacteraemia, Substance Use Disorders, Intravenous Substance Abuse
- Trial name
- SUDDEN-OUT (NCT04847921)
- Testing
- Dalbavancin
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- University of Colorado, Denver